Central Effect of Atrial Natriuretic Polypeptide on Angiotensin II-stimulated Vasopressin Secretion in Conscious Rats
Overview
Affiliations
The effect of intracerebroventricular (i.c.v.) treatment of alpha-human atrial natriuretic polypeptide on the vasopressin secretion induced by i.c.v. injection of angiotensin II was studied in conscious, unrestrained rats. Pretreatment of alpha-human atrial natriuretic polypeptide (5 micrograms) significantly inhibited the angiotensin II (100 ng)-stimulated vasopressin secretion. This result suggests that atrial natriuretic polypeptide plays regulatory roles in vasopressin secretion in the central nervous system.
Nakao K Proc Jpn Acad Ser B Phys Biol Sci. 2019; 95(9):538-567.
PMID: 31708497 PMC: 6856003. DOI: 10.2183/pjab.95.037.
Ito S, Ohtsuki S, Katsukura Y, Funaki M, Koitabashi Y, Sugino A J Cereb Blood Flow Metab. 2010; 31(2):457-66.
PMID: 20628403 PMC: 3049501. DOI: 10.1038/jcbfm.2010.108.
Nakao K, Yasoda A, Ebihara K, Hosoda K, Mukoyama M J Mol Med (Berl). 2009; 87(10):1029-39.
PMID: 19730806 DOI: 10.1007/s00109-009-0515-7.
Kallaras C, Angelopoulos N, Bountzioukas S, Mavroudis K, Karamouzis M, Guiba-Tziampiri O J Endocrinol Invest. 2005; 27(9):844-53.
PMID: 15648549 DOI: 10.1007/BF03346279.
Kallaras C, Angelopoulos N, Apostolakis M, Bountzioukas S, Guiba-Tziampiri O, Mavroudis K J Endocrinol Invest. 1998; 21(4):200-10.
PMID: 9624593 DOI: 10.1007/BF03347304.